Etihad Cargo Signs MoU for Sustainable Pharmaceutical Transportation
Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has entered into a memorandum of understanding (MOU) with B Medical Systems.
The MOU, which was announced during the BIO International Convention, being held in San Diego, USA, will see Etihad Cargo partner with B Medical Systems to develop and launch an airline-specific passive temperature-controlled solution for the transportation of vaccines and pharmaceuticals.
Etihad Cargo will collaborate with Luxembourg-based manufacturer and global distributor of medical refrigeration devices, B Medical Systems, to develop more sustainable temperature-controlled container units that work utilising passive cooling technology.
The units will retain temperatures from -80 to 25 degrees Celsius for up to five days without requiring an external power source, with load capabilities ranging from two to 1,500 litres.
Through the reduction in power needed to maintain the temperature for temperature-sensitive pharmaceutical shipments, these units will significantly reduce carbon emissions.
Further adding to the sustainability of the containers, their robust design and multi-use capabilities enable an operational life of over ten years. B Medical Systems' current product portfolio includes products that use solar energy as well as green refrigerants.
Martin Drew, Etihad Aviation Group's Senior Vice President – Sales & Cargo, said: "While other traditional active container providers are offering containers fit for multi-modal transportation, Etihad Cargo is the first airline globally to collaborate with a partner in the development and launch of units specifically tailored to air transportation.
"While the aviation sector only accounts for 4% of global carbon emission today, if the sector continues to grow at its current pace, it could account for up to 25 per cent of emissions by 2050.
"This is why it is so important for the sector to invest in more sustainable solutions for its customers. Partnering with B Medical Systems is the latest step by Etihad Cargo to achieve its sustainability targets."
Mr. Jesal Doshi, Deputy CEO of B Medical Systems, said: "Our mission at B Medical Systems is to create technology that helps save lives across the world. Transportation of temperature-sensitive specimens needs a robust cold chain."
Trials of the sustainable container units will commence shortly, and a commercial launch date will be announced following the successful completion of the trials.
The Abu Dhabi delegation to the US witnessed the participation of ten key entities in the life science ecosystem in Abu Dhabi, including the Department of Health – Abu Dhabi (DoH), Abu Dhabi Investment Office (ADIO), Mubadala Health, G42 Healthcare, Abu Dhabi Ports, ADQ, Etihad Cargo, Khalifa University, Hayat-vax and Pure Health.